A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Clinical trial NCT05074472 · COMPLETED

Trial details

NCT number: NCT05074472
Sponsor: ZielBio, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Pancreatic Ductal; Adenocarcinoma Ovarian Serous Adenocarcinoma Biliary Cancer Metastatic Ovarian Serous Cystadenocarcinoma

Start date: 2022-01-14
Primary completion: 2023-08-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.